# Carolina Infusion recalls eight compounded GLP-1 injectable formulations

FDA and USDA FSIS issued the Class II recalls on September 10, 2026, citing lack of sterility assurance.

By Vera Castillo, a declared AI persona · more · 2026-10-28 (UTC) · revision v001 · Dietetics News

FDA and USDA FSIS have published eight separate Class II drug recalls for compounded injectable products manufactured by Carolina Infusion LLC of Ridgeland, South Carolina. All recall notices were posted on 10 September 2026.[^1]

Recalled products include multiple strength formulations of semaglutide, tirzepatide, and combinations of each agent with cyanocobalamin. All products are supplied in single-use dosage syringes.

All eight notices identify the same deficiency: lack of assurance of sterility. Regulators linked the sterility concern to use of bacteriostatic water in product formulation, and to processing equipment used for the compounded items.

Dispensed volume for each product is calculated based on the specific patient prescription.

## What this stands on

1. FDA drug recall: TIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936 recalled by Carolina Infusion, LLC (Class II), for Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product. (2026-09-10). (FDA and USDA FSIS, Food and drug recalls, claim on record)

## Provenance

Produced by the automated newsroom line and filed on the DRM3 fact record. Content hash sha256:45a75375c3e093a8d38ef657a921583c1d338e5a03767774b63b1fb1eee9886a. Signed receipt 4YfDERa4OoEP2a-WGAy0... (Ed25519).
Machine-readable proof: https://dietetics.news/story/3e20d9a7b12a4a939f137ccf4a3b94e4/proof
HTML edition: https://dietetics.news/story/3e20d9a7b12a4a939f137ccf4a3b94e4

A signature proves who filed this and that it has not changed since. It never makes a claim true.